News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss L.A. McKeown November 07, 2025
News Conference News TCT 2025 At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I Yael L. Maxwell November 07, 2025
News Conference News TCT 2025 SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI Caitlin E. Cox November 06, 2025
News Daily News Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages Todd Neale November 06, 2025
News Conference News TCT 2025 ‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains Yael L. Maxwell November 05, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025